Surprisingly, high ARHGAP11A level was also reported to correlate with better prognosis in gastric cancer patients due to the detrimental effects on the suppressive TIME [20], which is inconsistent with its gastric cancer-promoting role. The gene discussed is ARHGAP11A; the disease is gastric cancer.